SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-17-000058
Filing Date
2017-06-22
Accepted
2017-06-22 16:41:17
Documents
1
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149816406095525.html 4  
1 FORM 4 wf-form4_149816406095525.xml 4 4256
  Complete submission text file 0001274644-17-000058.txt   5738
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O DOMAIN ASSOCIATES ONE PALO SQ PRINCETON NJ 08542
Business Address
WEBER ECKARD (Reporting) CIK: 0001279800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 17925517